ArticleArchives of toxicology2026
Translational medicine protocol for proteomics clinical research on snakebite envenoming: contributions for develop studies in mechanisms and new biomarkers.
Article in Archives of toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Translational research utilizing mass spectrometry to identify and validate biomarkers requires high-quality samples to maintain the integrity of research results. Key steps, including study design and sample/data quality control, are often overlooked or undervalued, which can compromise the consistency, accuracy, and verifiability of scientific and clinical outcomes. This is a prospective, longitudinal, multicenter cohort clinical trial that is recruiting participants who are victims of snakebite in Brazil and healthy individuals. Previously published studies on clinical trials and clinical-epidemiological research related to snakebites have identified universal measures and their categories, which were used to develop the study design and prepare the Case Report Forms. The biorepository presents a collection of clinical and epidemiological data, images of clinical manifestations, results of laboratory tests, and biological samples (serum and plasma in the presence of EDTA and sodium citrate). This article presents recommendations for essential steps in designing and implementing a mass spectrometry-based biomarker and mechanistic study focused on snakebite envenomation. We outline critical reporting models for conducting each phase of clinical data acquisition, such as collecting biological materials (serum and blood plasma) and processing samples to minimize the study's pre-analytical variables. The guidelines provided, covering everything from study design to implementation and data interpretation, serve as a reference to increasing the rigor and reproducibility of clinical proteomics studies. The results of this study can transcend basic research, connecting technological development to real clinical application, optimizing diagnosis and monitoring, but also contributing to reducing the economic burden, morbidity and mortality associated with these accidents.
Indexed as
Identifiers
41511520What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.